Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests enalapril to shield new moms' hearts after preeclampsia

NCT ID NCT07222852

Recruiting now Disease control Sponsor: Women and Infants Hospital of Rhode Island Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 3 times

Summary

This study looks at whether giving enalapril, a standard blood pressure medicine, to women who had preeclampsia during pregnancy can help control their blood pressure after childbirth. Researchers will enroll 60 postpartum women and randomly assign them to enalapril or usual care. The main goal is to see if women are willing to join and stick with the study, while also tracking blood pressure changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
enalapril
What this could lead to
If successful, this could show that enalapril is a safe and effective way to manage blood pressure after preeclampsia, potentially reducing long-term heart risks.
What could go wrong
This is a small feasibility study with only 60 participants, so results may not apply to all women. It focuses on enrollment and retention, not long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertension, pregnancy-induced hypertensive disorder preeclampsia Toxemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GESTATIONAL HYPERTENSION GESTATIONAL HYPERTENSION AFTER CHILDBIRTH HYPERTENSION HYPERTENSIVE DISORDER OF PREGNANCY PREECLAMPSIA

Contacts and locations

Locations

  • Women and Infants Hospital

    RECRUITING

    Providence, Rhode Island, 02906, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.